A key component of any R&D Productivity measure is generally associated with cost. As such, it is fundamental to understand how much it costs to pursue any given drug development project whether it be internally, with a co-development partner or as part of a licensing or acquisition deal. KMR Group has worked with companies to devise a reliable, robust, and systemic way to extract the cost incurred for each project in your portfolio using a top-down approach making the final figures appropriate and comparable for benchmarking, forecasting, and planning or to calculate the full cost of drug development

By pooling data beyond what any company could gather and analyze on its own, the application gives users reliable comparisons of the cost for any given phase of development across projects, by project characteristic (e.g., Alzheimer’s), and normalized by factors known to be statistically significant in driving cost (e.g., patients, molecule size). The application provides the basis for enhanced project and portfolio planning and more effective decisions